Prevalence of hypertension in AMI varies from 31% to 50% in various studies 2 . There is a paucity of data on hemodynamic and electrical complications of AMI in hypertensive patients. Mauri et al 3 reported an increased incidence of sudden death in AMI patients with a history of hypertension. On the other hand Abrignani et al 4 found lower incidence of shock, ventricular fibrillation, conduction disturbances, cardiac rupture and intracardiac thrombus in hypertensive patients with first MI, while atrial fibrillation was more common in these patients. More recently Rombek et al 5 [10] [11] [12] [13] [14] [15] [16] [17] shock, pulmonary oedema, ventricular tachycardia and/ or ventricular fibrillation and third degree atrioventricular(AV) block. Other studies did not show relevant difference for in-hospital and 6 month's mortality in hypertensive and normotensive patients with MI. 6 Prevalence of hypertension as well as coronary artery disease is increasing in countries of Indian subcontinent, including Bangladesh. Because of increasing number of hypertensive subjects developing acute myocardial infarction, it is an important subject to give attention. Hence, the study was done to estimate the in-hospital complications and outcome of AMI among hypertensive subjects.
Aim of Study
To analyze the in-hospital complication and outcome of AMI in hypertensive subjects and compare it with age and sex matched normotensive AMI patients.
Material & Method
Study design-prospective observational;case control
Inclusion criteria-first onset AMI patient with antecedent hypertension or newly diagnosed hypertension Exclusion criteria-i.patients with previous history of myocardial infarction.ii.patients with previous baseline ECG findings of left bundle branch block, pre-excitation syndrome
The study was conducted in the coronary care unit of Chittagong Medical College Hospital.The study period was one year (April, 2014 to March, 2015).We found a total of 112 patients in each group.As control, we randomly selected age and sex matched normotensive individuals with AMI. The study protocol was approved by the ethical committee on human research of the institute. Patient's characteristics, location and types of AMI, diagnostic and therapeutic measures undertaken and various complications were recorded. AMI was diagnosed if at least two of the following criteria were met 7 : (i) typical chest pain lasting for at least 30 min and not relieved by nitrates (ii) ST segment and/or T-wave changes suggestive of myocardial infarction and (iii) serum troponin-i or creatine phosphokinase(CK) concentration of more then twice the upper limit of normal range. The patents were categorized as having antecedent hypertension if the diagnosis was known by the patients or his attendant to having been made by their family physician, pre-admission records showed that they were hypertension and/or they were receiving anti-hypertensive drugs. A diagnosis of new hypertension were made when BP was <140/90 mmHg on receiving the patient that persisted in that range after the patient's condition settled (in 1-2 hrs DM, dyslipidaemia and a positive family history of CAD were significantly higher in hypertensives subjects compared with normotensives. Normotensive subjects had a higher prevalence of smoking compared with hypertensives (not statistically significant).
Hypertensive AMI subjects showed a higher prevalence of co-morbidities as shown in Majority of the hypertensive subjects (69%) presented to the CCU within 12 hrs of onset of their chest pain. Whereas, 55% of the normotensive subjects presented within 12 hrs of onset of their chest pain (p<0.05). Thus a greater number of hypertensive subjects were being thrombolysed (57.1% vs 50.9%) compared with normotensives, even though patients with BP e"160/ 110mmHg were excluded from therapy.
Pharmacologic treatment undertaken in the two groups are shown in table V.
A higher percentage of hypertensive subjects received low molecular weight heparin (LMWH) compared with the normotensives consistent with the higher NSTEMI cases among the hypertensives, all of whom received LMWH. Other cardioprotective drugs (beta blockers, ACEI) were used significantly more in hypertensive subjects. 
Evolving Complications:
Analysis of arrhythmic complications developing in the two study populations shows that a significantly higher prevalence of paroxysmal atrial fibrillation and a lower prevalence of conduction disturbance (AV block) and ventricular arrhythmia were found in hypertensives compared with normotensives Table VII shows the various mechanical complications developing in the two study populations.
Hypertensive AMI paients had a higher prevalence of LV failure (Killip class 2-4).A significantly higher percentage of cardiogenic shock (4.5% vs 9.8%, p<0.01) was found among the normotensive subjects compared with hypertensives. Analysis of ischemic complications (Table  VIII) shows that a significantly higher reinfarction rate was present in the hypertensive group.
Mean hospital stay of the two groups were not significantly different (9±2.7 days in hypertensives vs.9±1.8 days in normotensives) .Echocardiographic examination revealed a higher left ventricular ejection fraction(LVEF) among the hypertensives compared with the normotensives (0.51±0.13 vs.0.47±0.15).In-hospital mortality in the two groups are shown in table IX.
There was significantly lower in-hospital mortality among the hypertensive AMI subjects compared with the normotensive AMI subjects. 
Discussion:
The role of arterial hypertension in relation to in-hospital outcome in AMI has not been definitely established. Available evidence does not clearly show an increased rate of adverse outcome after AMI including stroke, heart failure and cardiovascular death among hypertensives 9 . Hypertension has been found to be a weak predictor of death in AMI patients by several investigators 10 . Muri et al 3 described that the increased risk of hemodynamic complications and death is related to the extend and expansion of MI, an anterior wall involvement, an increased extent of CAD, the presence of severe ventricular arrhythmias and myocardial rupture. Mortality from CAD rises continuously with increasing levels of systolic and diastolic BP 14 . However the relationship between the two is complex.
Prevalence of hypertension increases with increase in age, which is itself an important predictor of poor outcome in AMI 15 . Despite a global reduction in mortality from AMI in general population it remains still high among elderly 16 . Mortality from AMI is also high among females 4 . In an attempt to exclude age and sex as confounding factor we matched normotensives AMI patients by these factors. Hypertension was found to be combined with increased associated co-morbidities in the form of cerebrovascular disease, peripheral arterial disease, renal failure, diabetes, dyslipidemia and chronic obstructive airway disease 4 and on the basis of observations of other authors, greater target organ damage, such as nephropathy, microalbuminuria etc. 11 . Our hypertensive AMI patients had a higher prevalence of co-morbidities (table-2) such as DM, dyslipidemia, chronic kidney disease, chronic obstructive airway disease and history of revascularization which is in agreement with the findings of Ascenzu et al 17 . We did not found any significant difference regarding anterior or inferior location of AMI in our patients but a significantly higher rates of non STelevation MI (19.9% vs 15.9%, P<0.05) was found in hypertensives subjects compared with normotensives. A higher prevalence of non-ST elevated MI(NSTEMI) among hypertensives were also described in epidemiologic studies, where chronic hypertension was found as the most prevalent risk factors 13 . This higher prevalence of NSTEMI cases among the hypertensives may have also contributed to the lower in-hospital complications and mortality which is also in agreement with the findings of Abrigrnin et al 4 . Hypertensive subjects are known to have severe coronary atherosclerosis 19 which allows development of more collateral circulation. It explains the more NSTEMI cases among the hypertensives.
Most of the studies regarding links between hypertension and MI consider patients with a previous history of hypertension but data are lacking regarding patients who do not have antecedent hypertension but showed elevated BP values during their hospital stay for AMI. A study on patients with AMI admitted within 6 hours of onset of pain 31.7% patients had an elevated BP (e"180/ 100 mmHg) on presentation, only 6.3% of them had elevated BP after 6 hours though not treated with antihypertensive drugs 20 . We found such new cases of hypertension in 8% of our patients. We undertook a controlled reduction of BP in our AMI patients with hypertension in the CCU. Patients with long standing uncontrolled hypertension can not tolerate rapid great reduction of BP. The hypertensive myocardium is sensitive to BP lowering below a critical level. A rapid reduction of diastolic BP may potentially be more dangerous to the heart. Result of a recent analysis of AMI treated early with ACE inhibitors suggest caution in patients with antecedent hypertension but with low or normal BP at presentation, as these patients showed a higher first day mortality 25 . The recommended BP target in hypertensive AMI subjects is not completely clear.
Further studies are needed to define the issue more clearly.
Analysis of arrhythmic complications showed that only paroxysmal AF was found to be more frequent in our hypertensive patients. Other arrhythmias and AV block were more in normotensive subjects. This is in contrast to the general concept that hypertensive individuals are more prone to cardiac arrhythmias 21 . Abrignani et al 4 found an almost similar findings in their hypertensive patients with first time MI. A smaller necrotic area and presence of well developed collateral may better preserve conduction pathway, explaining the lesser prevalence of conduction disturbance and ventricular arrhythmias in hypertensive subjects. A higher prevalence of paroxysmal AF among our hypertensive subjects may be related to left atrial enlargement and chronically elevated left atrial pressure 22 . Prevalence of cardiogenic shock was significantly lower in our hypertensive patients (4.5% vs 9.8%, P<0.01) compared with the normotensives. Cardiogenic shock remains the leading cause of death in patients hospitalized with AMI 18 but its incidence has been greatly reduced by the use of reperfusion therapy through mechanical revascularization. Because of lack of mechanical revascularization and IABP facilities we could only undertake pharmacologic reperfusion with i.v. thrombolytic and conservative management of cardiogenic shock with inotropes. A higher percentage of our hypertensive ST elevated MI(STEMI) patients received thrombolytic therapy because of their early presentation to the CCU. Among the hypertensive STEMI subjects 69% presented to CCU within 12 hrs. Whereas only 55% of the normotensive subjects presented before 12 hrs. Higher rates of thrombolytic administration to the hypertensive subjects had possibly limited their infarct size as evident by the lower serum enzyme levels and a higher LV ejection fraction on echocardiography.
The lower incidence of cardiogenic shock and a better preserved LV function was responsible for significantly lower in-hospital mortality in the hypertensive AMI patients. Hypertensive subjects had a lower in-hospital mortality compared with the normotensives(6.2% vs. 10.7%,P<0.01).This is probably due to a better preserved LV function with a higher LVEF among the hypertensives (0.51±0.13 vs. 0.47±0.15) compared with the normotensives.This is in accordance with the findings of Abrignani et al 4 who are the first to show a significantly lower in-hospital complications and morbidity in hypertensive subjects with first time AMI compared with normotensives.This lower in-hospital mortality is in contrast to the findings of Richards et al 23 who found the same as 8.1% in their hypertensive patients compared with 4.4% among the normotensives. Their hypertensive patients also had a higher incidence of acute LV failure (33% vs. 24%) compared with the normotensives. Literature published so far shows that this is one of the few studies that showed a significantly better in-hospital outcome in hypertensive AMI subjects. Although this better outcome may not be maintained long term because of the greater severity of CAD in hypertensives and higher co-morbidities among them 25 and an adverse long term outcome is not unusual. Further studies may clarify the issue.
The study has got some important limitations:
i.Besides age and sex other patient characteristics were not excluded as confounding variables. ii.24 hours blood pressure recording of the study population were not possible. iii. primary PCI was not possible due to lack of facility. iv.only in-hospital outcome data are described here, post discharge follow up and long term complications and mortality data are lacking.
Conclusion:
Hypertensive AMI subjects had a better in-hospital outcome compared with normotensive AMI patients. These better outcomes is probably related to a better preserved LV function due to less infarct extension in hypertensive and more cases of NSTEMI among them. Early presentation of STEMI in the hypertensive group with higher rates of thrombolytic administration, more use of cardioprotective antihypertensive drugs, presence of extended collaterals in the hypertensives and yet unidentified factors may have also contributed to the better in-hospital outcome.
